Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  10/01/2001
 
Trade Name:  Betapace
 
Generic Name or Proper Name (*):  sotalol
 
Indications Studied:  Arrhythmia
 
Label Changes Summary:  Analysis of 2 trials provided information on PK and PD in children 3 days  12 years; safety and efficacy have not been established Information on dose, pharmacokinetics and AE's Pharmacokinetics: BSA most important covariate and more relevant than age Smaller children (BSA < 0.33 m2) showed tendency for larger change in QTc and increased frequency of prolongation of the QTc interval as well as greater beta-blocking effects Individualized dosing on a mg/m2 basis Information on preparation of a suspension
 
Product Labeling:  Labeling  Opens a new window
 
BPCA(B):  B
 
Sponsor:  Berlex
 
Pediatric Exclusivity Granted Date:  01/06/2000
 
NNPS:  FALSE'
 
Therapeutic Category:  Antiarrhythmic
 
-
-